First-line therapy in T2D: Has Metformin been “dethroned

Authors

Joshua J Neumiller, ProvidenceFollow
Radica Alicic, ProvidenceFollow

Document Type

News Article

Publication Date

8-1-2023

Keywords

washington; prmc; spokane

Clinical Institute

Kidney & Diabetes

Specialty

Endocrinology

Specialty

Nephrology

Comments

Medscape

Recommended Citation

Neumiller, Joshua J and Alicic, Radica, "First-line therapy in T2D: Has Metformin been “dethroned" (2023). Articles, Abstracts, and Reports. 8236.
https://digitalcommons.providence.org/publications/8236